Enhancing the effectiveness of programs and strategies to prevent youth smoking: a comparative realist evaluation of 7 European cities

Acronym

SILNE-R

Description of the granted funding

Cigarette smoking is a main risk factor for premature disease, disability and death in Europe, especially in disadvantaged groups. Prevention of youth smoking is crucial to any strategy aimed at reducing this disease burden in the future. Several potentially effective strategies and programs are available to address youth smoking. However, in practice their impact often appears to be limited, especially among socially disadvantaged youth. There is very little systematic evidence on HOW smoking prevention strategies and programs worked in practice, and WHY some programs seemed to influence youth smoking only in some settings or groups. Yet, such evidence is urgently needed to enable decision makers to use the resources available for smoking prevention in the most effective and equitable way. We will generate such evidence by addressing these HOW and WHY questions in a comparative approach. For Finland, Ireland, Germany, Netherlands, Belgium, Italy and Portugal, we aim to assess HOW strategies and programs to prevent smoking in national and local settings affected smoking behaviour of 16 year olds. Moreover, we aim to assess HOW and WHY this impact varied according to city, school, gender, and socioeconomic group. We will be among the first to apply the approach of “realist evaluation” to the evaluation of preventive programs, and to use this innovative approach to compare European countries. We will acquire primary data that are comparable across these countries, including a quantitative survey among 10,000+ students, and in-depth structured interviews with students and various stakeholders. We expect to make a major contribution to the reduction of disease burden and health inequalities among future elderly populations. We will apply a new method for learning from different countries, and for generating the fine-grained evidence that is needed to develop youth smoking prevention programs that are context-sensitive, cost-effective and equity-oriented.
Show more

Starting year

2015

End year

2018

Granted funding

363 718.75 €
Participant
Academisch Medisch Centrum bij de Universiteit van Amsterdam (NL)
427 028.75 €
Coordinator
UNIVERSIDADE NOVA DE LISBOA (PT)
367 968.75 €
Participant
EUROPEAN NETWORK FOR SMOKING PREVENTION (BE)
112 343.75 €
Participant
TobaccoFree Research Institute Ireland LBG (IE)
253 125 €
Participant
UNIVERSITA DEGLI STUDI DI CASSINO E DEL LAZIO MERIDIONALE (IT)
154 687.5 €
Participant
MARTIN-LUTHER-UNIVERSITAET HALLE-WITTENBERG (DE)
363 218.75 €
Participant
THE UNIVERSITY OF EDINBURGH (UK)
303 125 €
Participant
UNIVERSITEIT MAASTRICHT (NL)
282 343 €
Participant
UNIVERSITEIT MAASTRICHT (NL)
282 343.75 €
Participant
UNIVERSITE CATHOLIQUE DE LOUVAIN (BE)
372 437.5 €
Participant

Amount granted

2 999 998 €

Funder

European Union

Funding instrument

Research and Innovation action

Framework programme

Horizon 2020 Framework Programme

Call

Programme part
Health (5290)
Preventing disease (5295)
Topic
Evaluating existing screening and prevention programmes (PHC-06-2014)
Call ID
H2020-PHC-2014-two-stage

Other information

Funding decision number

635056

Identified topics

public health, occupational health